Literature DB >> 32016820

Progesterone and Breast Cancer: an NCI Workshop Report.

Neeraja Sathyamoorthy1, Carol A Lange2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32016820     DOI： 10.1007/s12672-020-00379-1

Source DB:  PubMed          Journal:  Horm Cancer        ISSN： 1868-8497            Impact factor:   3.869


× No keyword cloud information.
  61 in total

1.  Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.

Authors:  Renate Louw-du Toit; Meghan S Perkins; Janet P Hapgood; Donita Africander
Journal:  Biochem Biophys Res Commun       Date:  2017-07-12       Impact factor: 3.575

2.  Detection of progesterone receptor forms A and B by immunohistochemical analysis.

Authors:  P A Mote; J F Johnston; T Manninen; P Tuohimaa; C L Clarke
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

3.  Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.

Authors:  D V Spicer; G Ursin; Y R Parisky; J G Pearce; D Shoupe; A Pike; M C Pike
Journal:  J Natl Cancer Inst       Date:  1994-03-16       Impact factor: 13.506

4.  Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations with clinicopathologic tumor parameters and expression of AP-1 factors.

Authors:  A M Bamberger; K Milde-Langosch; H M Schulte; T Löning
Journal:  Horm Res       Date:  2000

5.  DNA binding triggers tetramerization of the glucocorticoid receptor in live cells.

Authors:  Diego M Presman; Sourav Ganguly; R Louis Schiltz; Thomas A Johnson; Tatiana S Karpova; Gordon L Hager
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-05       Impact factor: 11.205

6.  Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.

Authors:  Andrea R Daniel; Emily J Faivre; Carol A Lange
Journal:  Mol Endocrinol       Date:  2007-08-23

7.  Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer.

Authors:  Caroline A Lamb; Victoria T Fabris; Britta Jacobsen; Alfredo A Molinolo; Claudia Lanari
Journal:  Endocr Relat Cancer       Date:  2018-07-10       Impact factor: 5.678

8.  Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.

Authors:  Jacques Bonneterre; Jacques Bosq; Philippe Jamme; Alexander Valent; Erard M Gilles; Alexander A Zukiwski; Suzanne A W Fuqua; Carol A Lange; Joyce O'Shaughnessy
Journal:  ESMO Open       Date:  2016-08-22

9.  Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities.

Authors:  Alison E Casey; Ankit Sinha; Rajat Singhania; Julie Livingstone; Paul Waterhouse; Pirashaanthy Tharmapalan; Jennifer Cruickshank; Mona Shehata; Erik Drysdale; Hui Fang; Hyeyeon Kim; Ruth Isserlin; Swneke Bailey; Tiago Medina; Genevieve Deblois; Yu-Jia Shiah; Dalia Barsyte-Lovejoy; Stefan Hofer; Gary Bader; Mathieu Lupien; Cheryl Arrowsmith; Stefan Knapp; Daniel De Carvalho; Hal Berman; Paul C Boutros; Thomas Kislinger; Rama Khokha
Journal:  J Cell Biol       Date:  2018-06-19       Impact factor: 10.539

10.  NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer.

Authors:  Hanan S Elsarraj; Kelli E Valdez; Yan Hong; Sandra L Grimm; Lawrence R Ricci; Fang Fan; Ossama Tawfik; Lisa May; Therese Cusick; Marc Inciardi; Mark Redick; Jason Gatewood; Onalisa Winblad; Susan Hilsenbeck; Dean P Edwards; Christy R Hagan; Andrew K Godwin; Carol Fabian; Fariba Behbod
Journal:  Cancer Res       Date:  2017-05-17       Impact factor: 12.701
View more
  5 in total

Review 1.  Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies.

Authors:  Vincenza Simona Delvecchio; Claudia Fierro; Sara Giovannini; Gerry Melino; Francesca Bernassola
Journal:  Discov Oncol       Date:  2021-10-08

2.  High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin.

Authors:  Natasa Bajalovic; Yu Zuan Or; Amanda R E Woo; Shi Hao Lee; Valerie C L Lin
Journal:  Biomedicines       Date:  2022-08-02

3.  Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.

Authors:  Meghan S Perkins; Renate Louw-du Toit; Hayley Jackson; Mishkah Simons; Donita Africander
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-15       Impact factor: 6.055

4.  Application of an in Vitro Assay to Identify Chemicals That Increase Estradiol and Progesterone Synthesis and Are Potential Breast Cancer Risk Factors.

Authors:  Bethsaida Cardona; Ruthann A Rudel
Journal:  Environ Health Perspect       Date:  2021-07-21       Impact factor: 9.031

Review 5.  Global mapping of cancers: The Cancer Genome Atlas and beyond.

Authors:  Carlo Ganini; Ivano Amelio; Riccardo Bertolo; Pierluigi Bove; Oreste Claudio Buonomo; Eleonora Candi; Chiara Cipriani; Nicola Di Daniele; Hartmut Juhl; Alessandro Mauriello; Carla Marani; John Marshall; Sonia Melino; Paolo Marchetti; Manuela Montanaro; Maria Emanuela Natale; Flavia Novelli; Giampiero Palmieri; Mauro Piacentini; Erino Angelo Rendina; Mario Roselli; Giuseppe Sica; Manfredi Tesauro; Valentina Rovella; Giuseppe Tisone; Yufang Shi; Ying Wang; Gerry Melino
Journal:  Mol Oncol       Date:  2021-07-20       Impact factor: 6.603
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.